INCY Incyte Corporation
Healthcare$97.16-0.26%ClosedMarket Cap: $19.41B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$108.55
Target (Median)
$107.00
Target Range
$90.00 - $135.00
Upside from current price: 11.7%
Rating Distribution
2 Strong Buy9 Buy15 Hold1 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-21 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-29 | Oppenheimer | maintain | Perform | Perform |
| 2026-04-29 | Stifel | maintain | Buy | Buy |
| 2026-04-15 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-25 | UBS | maintain | Neutral | Neutral |
| 2026-03-16 | Jefferies | downgrade | Hold | Buy |
| 2026-03-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-05 | Evercore ISI Group | maintain | In Line | In Line |
| 2026-02-18 | Barclays | maintain | Overweight | Overweight |
| 2026-02-11 | Wells Fargo | maintain | Equal Weight | Equal Weight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $8.99 | $6.23B | 16 |
| Sun Dec 31 | $9.57 | $6.56B | 13 |
| Mon Dec 31 | $3.48 | $4.69B | 11 |
| Tue Dec 31 | $4.05 | $4.82B | 5 |